Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
Beta Bionics (Nasdaq: BBNX), a leader in advanced diabetes management solutions, will release its Q2 2025 financial results on Tuesday, July 29, 2025, after market close. The company will host a conference call and webcast at 4:30 PM ET on the same day.
Investors can access the webcast through the company's investor relations website under the "Events & Presentations" section, where it will also be archived for future viewing. For those joining by phone, registration is available through a dedicated link that will provide dial-in details and a personal pin.
[]Beta Bionics (Nasdaq: BBNX), leader nelle soluzioni avanzate per la gestione del diabete, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 martedì 29 luglio 2025, dopo la chiusura del mercato. La società terrà una conference call e una webcast alle 16:30 ET dello stesso giorno.
Gli investitori potranno accedere alla webcast tramite il sito web delle relazioni con gli investitori nella sezione "Eventi e Presentazioni", dove sarà anche archiviata per la visione futura. Chi parteciperà telefonicamente potrà registrarsi tramite un link dedicato che fornirà i dettagli per la chiamata e un PIN personale.
Beta Bionics (Nasdaq: BBNX), líder en soluciones avanzadas para la gestión de la diabetes, publicará sus resultados financieros del segundo trimestre de 2025 el martes 29 de julio de 2025, después del cierre del mercado. La compañía realizará una llamada conferencia y una transmisión en vivo a las 4:30 PM ET ese mismo día.
Los inversores podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas en la sección "Eventos y Presentaciones", donde también quedará archivada para futuras consultas. Quienes se unan por teléfono pueden registrarse mediante un enlace dedicado que proporcionará los detalles de marcación y un PIN personal.
Beta Bionics (나스닥: BBNX)는 첨단 당뇨병 관리 솔루션 분야의 선두주자로서 2025년 2분기 재무 실적을 2025년 7월 29일 화요일 장 마감 후 발표할 예정입니다. 같은 날 오후 4시 30분(동부시간)에 컨퍼런스 콜과 웹캐스트를 진행합니다.
투자자들은 회사의 투자자 관계 웹사이트 내 "이벤트 및 프레젠테이션" 섹션을 통해 웹캐스트에 접속할 수 있으며, 이후 다시 볼 수 있도록 아카이브됩니다. 전화로 참여하는 분들은 전용 링크를 통해 등록할 수 있으며, 해당 링크에서 전화 접속 정보와 개인 PIN을 받을 수 있습니다.
Beta Bionics (Nasdaq : BBNX), un leader dans les solutions avancées de gestion du diabète, publiera ses résultats financiers du deuxième trimestre 2025 le mardi 29 juillet 2025, après la clôture du marché. La société organisera une conférence téléphonique et une webdiffusion à 16h30 ET le même jour.
Les investisseurs pourront accéder à la webdiffusion via le site web des relations investisseurs de la société dans la section « Événements et présentations », où elle sera également archivée pour une consultation ultérieure. Pour ceux qui participeront par téléphone, une inscription est disponible via un lien dédié qui fournira les informations d'appel et un code PIN personnel.
Beta Bionics (Nasdaq: BBNX), ein führendes Unternehmen für fortschrittliche Diabetes-Management-Lösungen, wird seine Finanzergebnisse für das 2. Quartal 2025 am Dienstag, den 29. Juli 2025, nach Börsenschluss veröffentlichen. Am selben Tag findet um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast statt.
Investoren können über die Investor-Relations-Website des Unternehmens unter der Rubrik "Events & Präsentationen" auf den Webcast zugreifen, wo er auch für spätere Ansicht archiviert wird. Teilnehmer, die telefonisch teilnehmen möchten, können sich über einen speziellen Link registrieren, der Einwahldaten und eine persönliche PIN bereitstellt.
- None.
- None.
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2025 financial results after the financial markets close on Tuesday, July 29, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time).
The link to the webcast will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay. To access the live call by phone, please use the following link, which will provide you with dial-in details and a personal pin: https://register-conf.media-server.com/register/BIc649100069fd4629a4ed5bf4826b8acb.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
When will Beta Bionics (BBNX) release Q2 2025 earnings?
What time is the Beta Bionics (BBNX) Q2 2025 earnings call?
How can I access Beta Bionics (BBNX) Q2 2025 earnings call?
Where can I find the replay of Beta Bionics (BBNX) Q2 2025 earnings call?
